We are looking for young people 2–17 years old to join a Crohn’s disease (CD) clinical research to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderately to severely active ulcerative colitis (including associated symptoms such as long-term diarrhea, abdominal cramps, diarrhea, chronic fatigue and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child may be able to to join.
